Kyowa Kirin (United States)
Kyowa Kirin North America is the North American arm of a Japanese-based global specialty pharmaceutical company focused on rare diseases and underserved medical conditions.
Last updated September 15, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Kyowa Kirin North America describes itself as a global specialty pharmaceutical company committed to serving people living with rare diseases and underserved medical conditions. It states that it is a Japanese-based biopharmaceutical company that focuses on rare disease, and that it designs next-generation antibodies and cell and gene therapies for patients with high unmet needs, including bone and mineral disorders, intractable hematological conditions, hemato-oncologic diseases and rare diseases. The company says it has invested in drug discovery and biotechnology innovation for more than 70 years and is guided by Wa, the Japanese ideal of selfless teamwork. In North America it operates under the Kyowa Kirin name, referring to Kyowa Kirin USA Holdings, Inc., Kyowa Kirin, Inc., BioWa Inc., and Kyowa Kirin Canada, Inc.
History
Kyowa Kirin North America's own history page presents the heritage of its two parent lineages, Kyowa and Kirin, describing them as two companies with a common mission, each rooted in the science of fermentation and grounded in Japanese traditional cultural values. The page states that the Kirin origin story begins in 1870 in the Japanese port city of Yokohama, where American entrepreneur William Copeland founds the Spring Valley Brewery, and that in time that brewery grows into a global company whose core product is Kirin Beer. The page also states that the combined heritage represents over 150 years of innovation and over 70 years of experience in life sciences on a global scale. Separately, the company states that it has invested in drug discovery and biotechnology innovation for more than 70 years.
Products and positioning
A global specialty pharmaceutical company focused on rare diseases and underserved medical conditions, describing itself as innovative like a biotech company while having the resources of a large pharmaceutical company.
Sources5 sources
- 1Specialty Pharmaceutical Company | Kyowa Kirin North Americakkna.kyowakirin.com
- 2History | Kyowa Kirin North Americakkna.kyowakirin.com
- 3Who We Are | Kyowa Kirin North Americakkna.kyowakirin.com
- 4Corporate Compliance | Kyowa Kirin North Americakkna.kyowakirin.com
- 5Kyowa Kirin (United States)wikidata.org
Cite this profile: Cite the canonical profile. /brand-wiki/kyowa-kirin-united-states · Editorial policy · How profiles are compiled